Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir PK/Safety in HIV/HCV Co-infected Patients
NCT00141284Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of nelfinavir in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Primary endpoint: Safety of nelfinavir. Started Oct 2005; status: completed.
02
Drugs
nelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00141284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141284.